Target type: biologicalprocess
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a camptothecin stimulus. [GOC:mah]
Camptothecin is a natural product that exhibits potent anti-cancer activity by targeting DNA topoisomerase I (Topo I). Topo I is a crucial enzyme involved in DNA replication, transcription, and repair, and it functions by transiently breaking the DNA strand to allow for the unwinding and relaxation of the DNA molecule. Camptothecin acts by trapping Topo I in a complex with the cleaved DNA, thus inhibiting the religation step and creating a persistent DNA break. This blocked ligation event results in the accumulation of single-stranded DNA breaks, which can lead to cell cycle arrest and ultimately apoptosis.
The cellular response to camptothecin begins with its uptake into the cell through passive diffusion or active transport mechanisms. Once inside the cell, camptothecin binds to Topo I and forms a ternary complex with DNA, known as the "cleavable complex." This complex is stable and prevents the religation of the DNA strand, leading to the accumulation of single-stranded DNA breaks.
The presence of these DNA breaks activates a cascade of DNA damage response (DDR) pathways, including the ATM and ATR signaling pathways. These pathways trigger cell cycle arrest, allowing time for DNA repair mechanisms to function. However, if the DNA damage is too extensive or the repair mechanisms are overwhelmed, the cell will undergo programmed cell death (apoptosis).
The apoptotic pathway is triggered by the activation of caspase enzymes, which are key executioners of apoptosis. Caspases are activated in response to various apoptotic stimuli, including DNA damage. The activation of caspases leads to a series of events, including the breakdown of cellular components and the formation of apoptotic bodies, which are engulfed by neighboring cells.
In addition to apoptosis, camptothecin can also induce other cellular responses, including senescence and autophagy. Senescence is a state of irreversible cell cycle arrest that can be triggered by DNA damage, while autophagy is a process of cellular self-digestion that helps cells to recycle damaged components.
The cellular response to camptothecin is complex and involves a multitude of signaling pathways and cellular processes. The outcome of this response is determined by factors such as the dose and duration of camptothecin exposure, the cell type, and the genetic background of the organism. Understanding the cellular response to camptothecin is crucial for developing effective cancer treatments and for minimizing potential side effects.'
"
Protein | Definition | Taxonomy |
---|---|---|
DNA repair protein RAD51 homolog 1 | A DNA repair protein RAD51 homolog 1 that is encoded in the genome of human. [PRO:DNx] | Homo sapiens (human) |
Bloom syndrome protein | A RecQ-like DNA helicase BLM that is encoded in the genome of human. [PRO:DNx, UniProtKB:P54132] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
5-hydroxyindole | hydroxyindoles | human metabolite | |
methyl tryptophan, (l-trp)-isomer | |||
3-chloro-1-(2-chlorophenyl)-4-(4-morpholinyl)pyrrole-2,5-dione | maleimides | ||
3-chloro-1-(3,4-dichlorophenyl)-4-(4-morpholinyl)-1h-pyrrole-2,5-dione | 3-chloro-1-(3,4-dichlorophenyl)-4-(4-morpholinyl)-1H-pyrrole-2,5-dione: an inhibitor of RAD51 that disrupts homologous recombination in human cells; structure in first source | ||
1-(3,4-dichlorophenyl)-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)urea | ureas | ||
1-[4-fluoro-3-(trifluoromethyl)phenyl]-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)urea | ureas |